Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 40 (RPL21P40)

Target
RPL21P40
Molecular classification
Other, Pseudogene
01

Overview

Ribosomal protein L21 pseudogene 40 (RPL21P40) is a processed pseudogene—an inactive DNA sequence with high similarity to the protein-coding gene RPL21, which encodes the ribosomal protein L21, a component of the large 60S ribosomal subunit. Pseudogenes like RPL21P40 do not encode functional proteins. Recent research indicates that some ribosomal protein pseudogenes may play a regulatory role in gene expression, such as acting as competitive endogenous RNAs that modulate the parental gene expression via RNA interference pathways under some pathophysiological conditions (e.g., chronic stress, depression). RPL21P40 itself is not recognized as a drug target and does not have direct clinical relevance, but its parent gene (RPL21) is associated with rare genetic diseases such as hereditary hypotrichosis simplex. RPL21P40 is a pseudogene, not a functional protein or therapeutic target. It may participate in RNA-based regulation of ribosomal protein L21 (RPL21) expression but is not directly actionable as a target. No drugs, biomarkers, or safety concerns are associated.

Other names
RPL21P40RPL21_10_356RPL21P40 (formal alias)
02

Mechanism of action

Not applicable (no drugs or pharmacological agents act directly on this pseudogene)

03

Biological functions

Regulation of ribosomal protein gene expression (by RNA-based regulatory mechanisms such as RNA interference or ceRNA activity)No direct canonical cellular or molecular function as a protein
04

Disease associations

Other (may play a role in modulation of stress responses and possibly in certain diseases via regulation of its parental gene transcript, but not directly implicated as a causative or therapeutic target)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 40 (RPL21P40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 40 (RPL21P40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call